{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:06:43Z","timestamp":1784567203484,"version":"3.55.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe hypertrophic cardiomyopathy presenting in infancy occurs at an estimated frequency of 1:47,000 neonates and is characterized by rapid progression and poor prognosis. Differential diagnosis and timely identification of potentially treatable conditions amenable to genotype-specific therapeutic approaches are of critical importance; however, this is not always achievable in a timely manner. ACAD9 deficiency is a rare autosomal recessive disorder of mitochondrial complex I assembly and fatty acid \u00df-oxidation, typically presenting in early infancy with progressive cardiac hypertrophy and lactic acidosis. Differential diagnosis might be challenging due to phenotypic overlap with sarcomeric and other metabolic cardiomyopathies and limited availability of rapid diagnostic approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed comprehensive clinical, instrumental, and laboratory assessment of a 4-month-old girl with progressive biventricular hypertrophy, metabolic acidosis, persistent hyperlactatemia, and elevated NT-proBNP. Whole-exome sequencing (Illumina NovaSeq 6000; SureSelect All Exon V7) was followed by ACMG-based variant interpretation, database review (ClinVar), and segregation analysis with Sanger sequencing in the proband and parents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A homozygous missense variant NM_014049.5:c.659C &amp;gt; T (p.Ala220Val) in the\n                      <jats:italic>ACAD9<\/jats:italic>\n                      gene identified and classified as likely pathogenic (LP, Class IV). Carrier status was confirmed in both consanguine parents by Sanger sequencing. The variant is located near the catalytic core of ACAD9 and has been previously associated with severe complex I impairment and riboflavin-nonresponsive disease. Despite supportive metabolic and cardioprotective therapy, the proband died from an acute metabolic crisis and progressive heart failure before the genetic testing was complete. Parents were informed about genetic results and importance of genetic counseling and testing for further family planning.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights the clinical significance and importance of precise diagnostics in families burdened with early sibling death. Neonatal cardiomyopathy is a critical \u00abred flag\u00bb constellation warranting urgent molecular workup and appropriate therapy adjustment. Establishing a precise molecular diagnosis\u2014even when it cannot alter the proband\u2019s outcome\u2014carries essential value for family counseling, recurrence risk assessment (25% per pregnancy), and access to reproductive options including prenatal diagnosis and preimplantation genetic testing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1824617","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:37:08Z","timestamp":1784565428000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Homozygous mutation in the ACAD9 gene revealed in a pediatric patient initially diagnosed with familial cardiac hypertrophy"],"prefix":"10.3389","volume":"13","author":[{"given":"Natalia","family":"Kotlukova","sequence":"first","affiliation":[{"name":"Children\u2019s City Clinical Hospital Named After Z.A. Bashlyaeva","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasya","family":"Kadykova","sequence":"additional","affiliation":[{"name":"Russian Scientific Center of Surgery Named After Academician B.V. Petrovsky","place":["Moscow, Russia"]},{"name":"North-West State Medical University Named After I.I. Mechnikov","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisia","family":"Gorelova","sequence":"additional","affiliation":[{"name":"Children\u2019s City Clinical Hospital Named After Z.A. Bashlyaeva","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Dzik","sequence":"additional","affiliation":[{"name":"Russian Scientific Center of Surgery Named After Academician B.V. Petrovsky","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Islanov","sequence":"additional","affiliation":[{"name":"Russian Scientific Center of Surgery Named After Academician B.V. Petrovsky","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zaklyazminskaya","sequence":"additional","affiliation":[{"name":"Russian Scientific Center of Surgery Named After Academician B.V. Petrovsky","place":["Moscow, Russia"]},{"name":"Research Center for Medical Genetics Named After Academician N.P. Bochkov","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/children12080989","article-title":"Cardiac hypertrophy: a comprehensive review from prenatal life to young adulthood.","volume":"12","author":"Avesani","year":"2025","journal-title":"Children (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.4070\/kcj.2021.0153","article-title":"Hypertrophic cardiomyopathy in infants from the perspective of cardiomyocyte maturation.","volume":"51","author":"Seok","year":"2021","journal-title":"Korean Circ J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13023-018-0784-8","article-title":"Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency: is riboflavin supplementation effective?","volume":"13","author":"Repp","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000526022","article-title":"Severe antenatal hypertrophic cardiomyopathy secondary to ACAD9-related mitochondrial complex I deficiency.","volume":"14","author":"Dubucs","year":"2023","journal-title":"Mol Syndromol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/ng.706","article-title":"Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency.","volume":"42","author":"Haack","year":"2010","journal-title":"Nat Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/ejhg.2015.264","article-title":"High incidence and variable clinical outcome of cardiac hypertrophy due to ACAD9 mutations in childhood.","volume":"24","author":"Collet","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ymgme.2019.07.008","article-title":"Assessing the strength of evidence for genes implicated in fatty acid oxidation disorders using the ClinGen clinical validity framework.","volume":"128","author":"McGlaughon","year":"2019","journal-title":"Mol Genet Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/8904_2013_242","article-title":"A patient with complex i deficiency caused by a novel ACAD9 mutation not responding to riboflavin treatment.","volume":"12","author":"Nouws","year":"2014","journal-title":"JIMD Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1086\/519219","article-title":"A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.","volume":"81","author":"He","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cmet.2010.08.002","article-title":"Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I.","volume":"12","author":"Nouws","year":"2010","journal-title":"Cell Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"103153","DOI":"10.1016\/j.isci.2021.103153","article-title":"Molecular mechanism of interactions between ACAD9 and binding partners in mitochondrial respiratory complex I assembly.","volume":"24","author":"Xia","year":"2021","journal-title":"iScience"},{"key":"B13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ymgme.2016.05.005","article-title":"Evidence of a wide spectrum of cardiac involvement due to ACAD9 mutations: report on nine patients.","volume":"118","author":"Dewulf","year":"2016","journal-title":"Mol Genet Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.31083\/j.rcm.2019.02.5151","article-title":"Metabolic cardiomyopathy in pediatrics.","volume":"20","author":"Tril","year":"2019","journal-title":"Rev Cardiovasc Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1093\/hmg\/ddv074","article-title":"Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency.","volume":"24","author":"Schiff","year":"2015","journal-title":"Hum Mol Genet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/8904_2015_499","article-title":"Lethal neonatal progression of fetal cardiomegaly associated to ACAD9 deficiency.","volume":"28","author":"Lagoutte-Renosi","year":"2015","journal-title":"JIMD Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.humpath.2015.09.039","article-title":"Neonatal multiorgan failure due to ACAD9 mutation and complex I deficiency with mitochondrial hyperplasia in liver, cardiac myocytes, skeletal muscle, and renal tubules.","volume":"49","author":"Leslie","year":"2016","journal-title":"Hum Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ymgmr.2016.12.005","article-title":"An atypical presentation of ACAD9 deficiency: diagnosis by whole exome sequencing broadens the phenotypic spectrum and alters treatment approach.","volume":"10","author":"Aintablian","year":"2016","journal-title":"Mol Genet Metab Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/brain\/awq273","article-title":"Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene.","volume":"134","author":"Gerards","year":"2011","journal-title":"Brain"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jmd2.12157","article-title":"Successful pregnancy in a patient with mitochondrial cardiomyopathy due to ACAD9 deficiency.","volume":"56","author":"Jacobi-Polishook","year":"2020","journal-title":"JIMD Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.46563\/2686-8997-2023-4-4-215-225","article-title":"Hypertrophic cardiomyopathy and lactic acidosis in a child with acyl-CoA dehydrogenase 9 deficiency. Review of the literature and clinical observation.","volume":"4","author":"Gandaeva","year":"2023","journal-title":"L.O. Badalyan Neurol J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1515\/jpem-2019-0205","article-title":"Successful treatment of infantile-onset ACAD9-related cardiomyopathy with a combination of sodium pyruvate, beta-blocker, and coenzyme Q10.","volume":"32","author":"Kadoya","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"101905","DOI":"10.1016\/j.mito.2024.101905","article-title":"ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosis.","volume":"78","author":"Van Hove","year":"2024","journal-title":"Mitochondrion"},{"key":"B24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.hfc.2021.07.012","article-title":"The risk of sudden death in children with hypertrophic cardiomyopathy.","volume":"18","author":"Norrish","year":"2022","journal-title":"Heart Fail Clin"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies.","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/gim.2014.177","article-title":"Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.","volume":"17","author":"Parikh","year":"2015","journal-title":"Genet Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3343\/alm.2023.43.3.223","article-title":"Rapid targeted genomic testing: a powerful tool for diagnostic evaluation of critically ill neonates and infants with suspected genetic diseases.","volume":"43","author":"Jang","year":"2023","journal-title":"Ann Lab Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1824617\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:37:09Z","timestamp":1784565429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1824617\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":27,"alternative-id":["10.3389\/fmed.2026.1824617"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1824617","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"article-number":"1824617"}}